Starving out brain tumors: a reprogrammed lysine catabolism serves as a novel target for glioblastoma treatment.

Gül, Désirée; Krämer, Oliver H; Reinhardt, Christoph

Gül, Désirée; Krämer, Oliver H; Reinhardt, Christoph.

Afiliação

Gül D; Molecular and Cellular Oncology, Department of Otorhinolaryngology Head and Neck Surgery, University Medical Center, Johannes Gutenberg-University Mainz, 55131, Mainz, Germany.
Krämer OH; Department of Toxicology, University Medical Center, Johannes Gutenberg-University Mainz, 55131, Mainz, Germany.
Reinhardt C; Center for Thrombosis and Hemostasis (CTH), University Medical Center, Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, 55131, Mainz, Germany. Christoph.Reinhardt@unimedizin-mainz.de.

Signal Transduct Target Ther ; 8(1): 401, 2023 10 09.

Article em En | MEDLINE | ID: mdl-37813874

Assuntos

Neoplasias Encefálicas; Glioblastoma; Humanos; Glioblastoma/tratamento farmacológico; Glioblastoma/genética; Glioblastoma/metabolismo; Lisina/metabolismo; Neoplasias Encefálicas/tratamento farmacológico; Neoplasias Encefálicas/genética; Neoplasias Encefálicas/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google